Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Skin sensitisation: sensitising

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation, other
Type of information:
other: classification of constituents
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Remarks:
ECHA database
Qualifier:
no guideline followed
Principles of method if other than guideline:
The classification of constituents of Cymbopogon Winterianus was studied (ECHA website) and used to derive a classification for the UVCB itself using the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC) for eye irritation/serious eye damage.
GLP compliance:
no
Type of study:
other: calculation
Remarks on result:
other: Not relevant
Remarks on result:
other: not relevant
Remarks on result:
other: not relevant

The most important constituents with regard to skin sensitisation are 1,(+)-citronellal (CAS 2385-77-5), citronellol (CAS 1117-61-9) and geraniol (CAS 106-24-1), present at typical concentrations of 36.27%, 12.74% and 21.56% respectively. These are all classified as skin sensitiser (Skin Sens. 1 / H317).

Interpretation of results:
other: sensitising
Remarks:
based on CLP criteria
Conclusions:
The most important constituents are classified for skin sensitisation and are present well above the classification threshold of 1% for mixtures, as given in the CLP Regulation (1272/2008/EC). Based on this information, Cymbopogon Winterianus is also considered to be classified for skin sensitisation (Skin Sens. 1 / H317).
Executive summary:

The classification of constituents of Cymbopogon Winterianus was studied (ECHA website) and used to derive a classification for the UVCB itself using the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC) for eye irritation/serious eye damage. The most importantconstituents with regard to skin sensitisation are 1,(+)-citronellal (CAS 2385-77-5), citronellol (CAS 1117-61-9) and geraniol (CAS 106-24-1), present at typical concentrations of 36.27%, 12.74% and 21.56% respectively. These are all classified as skin sensitiser (Skin Sens. 1 / H317) and are present well above the classification threshold of 1% for mixtures, as given in the CLP Regulation (1272/2008/EC). Based on this information, Cymbopogon Winterianus is also considered to be classified for skin sensitisation (Skin Sens. 1 / H317).

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

The classification of constituents of Cymbopogon Winterianus was studied (ECHA website) and used to derive a classification for the UVCB itself using the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC) for eye irritation/serious eye damage. The most important constituents with regard to skin sensitisation are 1,(+)-citronellal (CAS 2385-77-5), citronellol (CAS 1117-61-9) and geraniol (CAS 106-24-1), present at typical concentrations of 36.27%, 12.74% and 21.56% respectively. These are all classified as skin sensitiser (Skin Sens. 1 / H317) and are present well above the classification threshold of 1% for mixtures, as given in the CLP Regulation (1272/2008/EC). Based on this information, Cymbopogon Winterianus is also considered to be classified for skin sensitisation (Skin Sens. 1 / H317).

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Based on the available data, Cymbopogon winterianus should be classified as a skin sensitiser (Skin Sens. 1 / H317) in accordance with the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC).